EDWARD WHOLIHAN

CIK 1719764 · Chief Financial Officer · last filed 2026-04-01

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$191.0K

Companies

2

Total Filings

17

Lifetime Open-Market Net

-$93.2K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KRMD Director 47,741 $4.00 $191.0K $0 11 2026-04-01
Allena Pharmaceuticals, Inc. (ALNA) Delisted Chief Financial Officer 189,822 $0.07 $14.2K -$93.2K 6 2020-12-18

Recent Filings · Page 2 of 2

17 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-10-06 KRMD Grant (A) +119 $326 EDGAR
2020-12-18 Allena Pharmaceuticals, Inc. (ALNA) Delisted Mixed +96,272 -$93.2K EDGAR
2020-05-29 Allena Pharmaceuticals, Inc. (ALNA) Delisted Grant (A) $0 EDGAR
2019-12-04 Allena Pharmaceuticals, Inc. (ALNA) Delisted Grant (A) $0 EDGAR
2019-03-04 Allena Pharmaceuticals, Inc. (ALNA) Delisted Grant (A) $0 EDGAR
2018-05-10 Allena Pharmaceuticals, Inc. (ALNA) Delisted Exer (M) +25,000 $39.8K EDGAR
2018-02-12 Allena Pharmaceuticals, Inc. (ALNA) Delisted Grant (A) $0 EDGAR
Showing 1117 of 17
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.